ALYSSA YATES: Open Payments
NPI 1871950220 · NEW ALBANY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,066 in 174 payments from 19 companies in 2025. Trend: 2023 $1,024 · 2024 $1,386 · 2025 $3,066
Food & beverage: $3,066
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 48 | $778 |
| Phathom Pharmaceuticals, Inc. | 27 | $406 |
| Janssen Biotech, Inc. | 19 | $315 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $220 |
| GENZYME CORPORATION | 9 | $203 |
| Ardelyx, Inc. | 13 | $200 |
| Gilead Sciences, Inc. | 8 | $180 |
| QOL Medical, LLC | 6 | $174 |
| Regeneron Healthcare Solutions, Inc. | 6 | $123 |
| Madrigal Pharmaceuticals | 4 | $100 |
Products named: RINVOQ, VOQUEZNA, DUPIXENT, TREMFYA, IBSRELA, ENTYVIO, Sucraid, CREON.
Industry payments across IN — which companies pay providers there.
